Widespread alterations in the synaptic proteome of the adolescent cerebral cortex following prenatal immune activation in rats

Brain, Behavior, and Immunity

Volumn 56, Issue , 2016, Pages 289-309

  Györffy, Balázs A ^a   Gulyássy, Péter ^b,c   Gellén, Barbara ^a,b   Völgyi, Katalin ^a,b   Madarasi, Dóra ^a   Kis, Viktor ^a   Ozohanics, Olivér ^b   Papp, Ildikó ^d   Kovács, Péter ^d   Lubec, Gert ^c   Dobolyi, Árpád ^b   Kardos, József ^a   Drahos, László ^b   Juhász, Gábor ^a,b   Kékesi, Katalin A ^a  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d CRU Hungary Kft   (Hungary)

Author keywords

Autism spectrum disorder (ASD); Cerebral cortex; Maternal immune activation (MIA); Neuroproteomics; Schizophrenia; Synaptosome

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; LIPOPOLYSACCHARIDE; PROTEOME;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; BRAIN DYSFUNCTION; CELL VACUOLE; CONTROLLED STUDY; CYTOSKELETON; EMBRYO DEVELOPMENT; ENERGY METABOLISM; EXPERIMENTAL STUDY; FEMALE; IMMUNOSTIMULATION; INTRACELLULAR TRANSPORT; NEOCORTEX; NONHUMAN; PATHOPHYSIOLOGY; POSTSYNAPSE; PREFRONTAL CORTEX; PRENATAL PERIOD; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROGENY; PROTEIN DETERMINATION; RAT; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPSE; SYNAPSE VESICLE; TANDEM MASS SPECTROMETRY; VALIDATION STUDY; ANIMAL; DISEASE MODEL; IMMUNOLOGY; MALE; METABOLISM; PATHOLOGY; PREGNANCY; PRENATAL EXPOSURE; PROCEDURES; PROTEOMICS; SYNAPTOSOME; WISTAR RAT;

ANIMALS; AUTISM SPECTRUM DISORDER; DISEASE MODELS, ANIMAL; FEMALE; LIPOPOLYSACCHARIDES; MALE; PREFRONTAL CORTEX; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROTEOME; PROTEOMICS; RATS; RATS, WISTAR; SCHIZOPHRENIA; SYNAPSES; SYNAPTOSOMES;

EID: 84962850121     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2016.04.002     Document Type: Article

References (156)

1. Abramoff M.D., Magalhaes P.J., Ram S.J. Image Processing with ImageJ. Biophotonics Int. 2004, 11(7):36-42.
2. Ahlsén G., Rosengren L., Belfrage M., Palm A., Haglid K., Hamberger A., Gillberg C. Glial fibrillary acidic protein in the cerebrospinal fluid of children with autism and other neuropsychiatric disorders. Biol. Psychiatry 1993, 33(10):734-743. 10.1016/0006-3223(93)90124-V.
3. Akyol O., Yanik M., Elyas H., Namli M., Canatan H., Akin H., Yuce H., Yilmaz H.R., Tutkun H., Sogut S., Herken H., Ozyurt H., Savas H.A., Zoroglu S.S. Association between Ala-9Val polymorphism of Mn-SOD gene and schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29(1):123-131. 10.1016/j.pnpbp.2004.10.014.
4. Anitha A., Nakamura K., Thanseem I., Matsuzaki H., Miyachi T., Tsujii M., Iwata Y., Suzuki K., Sugiyama T., Mori N. Downregulation of the expression of mitochondrial electron transport complex genes in autism brains. Brain Pathol. 2013, 23(3):294-302. 10.1111/bpa.12002.
5. Ashdown H., Dumont Y., Ng M., Poole S., Boksa P., Luheshi G.N. The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia. Mol. Psychiatry 2006, 11(1):47-55. 10.1038/sj.mp.4001748.
6. Atladóttir H.O., Thorsen P., Østergaard L., Schendel D.E., Lemcke S., Abdallah M., Parner E.T. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J. Autism Dev. Disord. 2010, 40(12):1423-1430. 10.1007/s10803-010-1006-y.
7. Bader V., Tomppo L., Trossbach S.V., Bradshaw N.J., Prikulis I., Leliveld S.R., Lin C.Y., Ishizuka K., Sawa A., Ramos A., Rosa I., García Á., Requena J.R., Hipolito M., Rai N., Nwulia E., Henning U., Ferrea S., Luckhaus C., Ekelund J., Veijola J., Järvelin M.R., Hennah W., Korth C. Proteomic, genomic and translational approaches identify CRMP1 for a role in schizophrenia and its underlying traits. Hum. Mol. Genet. 2012, 21(20):4406-4418. 10.1093/hmg/dds273.
8. Bale T.L., Baram T.Z., Brown A.S., Goldstein J.M., Insel T.R., McCarthy M.M., Nemeroff C.B., Reyes T.M., Simerly R.B., Susser E.S., Nestler E.J. Early life programming and neurodevelopmental disorders. Biol. Psychiatry 2010, 68(4):314-319. 10.1016/j.biopsych.2010.05.028.
9. Barakauskas V.E., Beasley C.L., Barr A.M., Ypsilanti A.R., Li H.Y., Thornton A.E., Wong H., Rosokilja G., Mann J.J., Mancevski B., Jakovski Z., Davceva N., Ilievski B., Dwork A.J., Falkai P., Honer W.G. A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophrenia. Neuropsychopharmacology 2010, 35(5):1226-1238. 10.1038/npp.2009.228.
10. Baron-Cohen S., Lombardo M.V., Auyeung B., Ashwin E., Chakrabarti B., Knickmeyer R. Why are autism spectrum conditions more prevalent in males?. PLoS Biol. 2011, 9(6):e1001081. 10.1371/journal.pbio.1001081.
11. Basil P., Li Q., Dempster E.L., Mill J., Sham P.C., Wong C.C., McAlonan G.M. Prenatal maternal immune activation causes epigenetic differences in adolescent mouse brain. Transl. Psychiatry 2014, 4:e434. 10.1038/tp.2014.80.
12. Beasley C.L., Pennington K., Behan A., Wait R., Dunn M.J., Cotter D. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes. Proteomics 2006, 6(11):3414-3425. 10.1002/pmic.200500069.
13. Behan A.T., Byrne C., Dunn M.J., Cagney G., Cotter D.R. Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression. Mol. Psychiatry 2009, 14(6):601-613. 10.1038/mp.2008.7.
14. Bilbo S.D., Schwarz J.M. Early-life programming of later-life brain and behavior: a critical role for the immune system. Front. Behav. Neurosci. 2009, 3:14. 10.3389/neuro.08.014.2009.
15. Boksa P. Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav. Immun. 2010, 24(6):881-897. 10.1016/j.bbi.2010.03.005.
16. Bozidis P., Hyphantis T., Mantas C., Sotiropoulou M., Antypa N., Andreoulakis E., Serretti A., Mavreas V., Antoniou K. HSP70 polymorphisms in first psychotic episode drug-naïve schizophrenic patients. Life Sci. 2014, 100(2):133-137. 10.1016/j.lfs.2014.02.006.
17. Braff D.L., Freedman R., Schork N.J., Gottesman I.I. Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophr. Bull. 2007, 33(1):21-32. 10.1093/schbul/sbl049.
18. Brahimi-Horn M.C., Ben-Hail D., Ilie M., Gounon P., Rouleau M., Hofman V., Doyen J., Mari B., Shoshan-Barmatz V., Hofman P., Pouysségur J., Mazure N.M. Expression of a truncated active form of VDAC1 in lung cancer associates with hypoxic cell survival and correlates with progression to chemotherapy resistance. Cancer Res. 2012, 72(8):2140-2150. 10.1158/0008-5472.CAN-11-3940.
19. Braunewell K.H., Dwary A.D., Richter F., Trappe K., Zhao C., Giegling I., Schönrath K., Rujescu D. Association of VSNL1 with schizophrenia, frontal cortical function, and biological significance for its gene product as a modulator of cAMP levels and neuronal morphology. Transl. Psychiatry 2011, 1:e22. 10.1038/tp.2011.20.
20. Bronson S.L., Ahlbrand R., Horn P.S., Kern J.R., Richtand N.M. Individual differences in maternal response to immune challenge predict offspring behavior: contribution of environmental factors. Behav. Brain Res. 2011, 220(1):55-64. 10.1016/j.bbr.2010.12.040.
21. Brown A.S. The environment and susceptibility to schizophrenia. Prog. Neurobiol. 2011, 93(1):23-58. 10.1016/j.pneurobio.2010.09.003.
22. Brown A.S. Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism. Dev. Neurobiol. 2012, 72(10):1272-1276. 10.1002/dneu.22024.
23. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., Bresnahan M., Babulas V.P., Susser E.S. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch. Gen. Psychiatry 2004, 61(8):774-780. 10.1001/archpsyc.61.8.774.
24. Brown A.S., Derkits E.J. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am. J. Psychiatry 2010, 167(3):261-280. 10.1176/appi.ajp.2009.09030361.
25. Buchsbaum M.S., Nenadic I., Hazlett E.A., Spiegel-Cohen J., Fleischman M.B., Akhavan A., Silverman J.M., Siever L.J. Differential metabolic rates in prefrontal and temporal Brodmann areas in schizophrenia and schizotypal personality disorder. Schizophr. Res. 2002, 54(1-2):141-150. 10.1016/S0920-9964(01)00361-9.
26. Budd J.M., Kisvárday Z.F. Communication and wiring in the cortical connectome. Front. Neuroanat. 2012, 6:42. 10.3389/fnana.2012.00042.
27. Burbaeva G.Sh., Savushkina O.K., Boksha I.S. Creatine kinase BB in brain in schizophrenia. World J. Biol. Psychiatry 2003, 4(4):177-183. 10.1080/15622970310029916.
28. Cai Z., Pan Z.L., Pang Y., Evans O.B., Rhodes P.G. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr. Res. 2000, 47(1):64-72. 10.1203/00006450-200001000-00013.
29. Callicott J.H., Bertolino A., Mattay V.S., Langheim F.J., Duyn J., Coppola R., Goldberg T.E., Weinberger D.R. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb. Cortex 2000, 10(11):1078-1092. 10.1093/cercor/10.11.1078.
30. Carlin R.K., Grab D.J., Cohen R.S., Siekevitz P. Isolation and characterization of postsynaptic densities from various brain regions: enrichment of different types of postsynaptic densities. J. Cell Biol. 1980, 86(3):831-845. 10.1083/jcb.86.3.831.
31. Casey L.C., Balk R.A., Bone R.C. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med. 1993, 119(8):771-778.
32. Chauhan A., Chauhan V. Oxidative stress in autism. Pathophysiology 2006, 13(3):171-181. 10.1016/j.pathophys.2006.05.007.
33. Chen J., Yu S., Fu Y., Li X. Synaptic proteins and receptors defects in autism spectrum disorders. Front. Cell Neurosci. 2014, 8:276. 10.3389/fncel.2014.00276.
34. Chess S. Follow-up report on autism in congenital rubella. J. Autism Child Schizophr. 1977, 7(1):69-81. 10.1007/BF01531116.
35. Cheung C., Yu K., Fung G., Leung M., Wong C., Li Q., Sham P., Chua S., McAlonan G. Autistic disorders and schizophrenia: related or remote? An anatomical likelihood estimation. PLoS One 2010, 5(8):e12233. 10.1371/journal.pone.0012233.
36. Chevalier F. Highlights on the capacities of "Gel-based" proteomics. Proteome Sci. 2010, 8:23. 10.1186/1477-5956-8-23.
37. Chiu S.L., Chen C.M., Cline H.T. Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo. Neuron 2008, 58(5):708-719. 10.1016/j.neuron.2008.04.014.
38. Cho K.O., Hunt C.A., Kennedy M.B. The rat brain postsynaptic density fraction contains a homolog of the Drosophila discs-large tumor suppressor protein. Neuron 1992, 9(5):929-942. 10.1016/0896-6273(92)90245-9.
39. Cohen R.S., Blomberg F., Berzins K., Siekevitz P. The structure of postsynaptic densities isolated from dog cerebral cortex. I. Overall morphology and protein composition. J. Cell Biol. 1977, 74(1):181-203. 10.1083/jcb.74.1.181.
40. Copeland S., Warren H.S., Lowry S.F., Calvano S.E., Remick D. Inflammation and the host response to injury investigators. Acute inflammatory response to endotoxin in mice and humans. Clin. Diagn. Lab. Immunol. 2005, 12(1):60-67.
41. Corradi A., Fadda M., Piton A., Patry L., Marte A., Rossi P., Cadieux-Dion M., Gauthier J., Lapointe L., Mottron L., Valtorta F., Rouleau G.A., Fassio A., Benfenati F., Cossette P. SYN2 is an autism predisposing gene: loss-of-function mutations alter synaptic vesicle cycling and axon outgrowth. Hum. Mol. Genet. 2014, 23(1):90-103. 10.1093/hmg/ddt401.
42. Craig A.M., Boudin H. Molecular heterogeneity of central synapses: afferent and target regulation. Nat. Neurosci. 2001, 4(6):569-578. 10.1038/88388.
43. De Rubeis S., Bagni C. Regulation of molecular pathways in the Fragile X Syndrome: insights into Autism Spectrum Disorders. J. Neurodev Disorder 2011, 3(3):257-269. 10.1007/s11689-011-9087-2.
44. Deb K., Chaturvedi M.M., Jaiswal Y.K. Comprehending the role of LPS in Gram-negative bacterial vaginosis: ogling into the causes of unfulfilled child-wish. Arch. Gynecol. Obstet. 2004, 270(3):133-146.
45. Deng M.Y., Lam S., Meyer U., Feldon J., Li Q., Wei R., Luk L., Chua S.E., Sham P., Wang Y., McAlonan G.M. Frontal-subcortical protein expression following prenatal exposure to maternal inflammation. PLoS ONE 2011, 6(2):e16638. 10.1371/journal.pone.0016638.
46. Deverman B.E., Patterson P.H. Cytokines and CNS development. Neuron 2009, 64(1):61-78. 10.1016/j.neuron.2009.09.002.
47. Diao W.F., Höger H., Chen W.Q., Pollak A., Lubec G. Estrous-cycle-dependent hippocampal levels of signaling proteins. Hippocampus 2007, 17(7):563-576. 10.1002/hipo.20293.
48. Dickerson D.D., Bilkey D.K. Aberrant neural synchrony in the maternal immune activation model: using translatable measures to explore targeted interventions. Front. Behav. Neurosci. 2013, 7:217. 10.3389/fnbeh.2013.00217.
49. Eaton S.L., Roche S.L., Llavero Hurtado M., Oldknow K.J., Farquharson C., Gillingwater T.H., Wishart T.M. Total protein analysis as a reliable loading control for quantitative fluorescent western blotting. PLoS ONE 2013, 8(8):e72457. 10.1371/journal.pone.0072457.
50. Edgar J.C., Miller G.A., Moses S.N., Thoma R.J., Huang M.X., Hanlon F.M., Weisend M.P., Sherwood A., Bustillo J., Adler L.E., Cañive J.M. Cross-modal generality of the gating deficit. Psychophysiology 2005, 42(3):318-327. 10.1016/S0920-9964(03)81176-3.
51. Edwards M.J. Hyperthermia in utero due to maternal influenza is an environmental risk factor for schizophrenia. Congenit Anom (Kyoto) 2007, 47(3):84-89. 10.1111/j.1741-4520.2007.00151.x.
52. Fallin M.D., Lasseter V.K., Avramopoulos D., Nicodemus K.K., Wolyniec P.S., McGrath J.A., Steel G., Nestadt G., Liang K.Y., Huganir R.L., Valle D., Pulver A.E. Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am. J. Hum. Genet. 2005, 77(6):918-936. 10.1086/497703.
53. Farrelly L., Föcking M., Piontkewitz Y., Dicker P., English J., Wynne K., Cannon M., Cagney G., Cotter D.R. Maternal immune activation induces changes in myelin and metabolic proteins, some of which can be prevented with risperidone in adolescence. Dev. Neurosci. 2015, 37(1):43-55. 10.1159/000368305.
54. Feyder M., Karlsson R.M., Mathur P., Lyman M., Bock R., Momenan R., Munasinghe J., Scattoni M.L., Ihne J., Camp M., Graybeal C., Strathdee D., Begg A., Alvarez V.A., Kirsch P., Rietschel M., Cichon S., Walter H., Meyer-Lindenberg A., Grant S.G., Holmes A. Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams' syndrome. Am. J. Psychiatry 2010, 167(12):1508-1517. 10.1176/appi.ajp.2010.10040484.
55. Föcking M., Lopez L.M., English J.A., Dicker P., Wolff A., Brindley E., Wynne K., Cagney G., Cotter D.R. Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia. Mol. Psychiatry 2015, 20(4):424-432. 10.1038/mp.2014.63.
56. Frankle W.G., Lerma J., Laruelle M. The synaptic hypothesis of schizophrenia. Neuron 2003, 39(2):205-216. 10.1016/S0896-6273(03)00423-9.
57. Frankland P.W., Sakaguchi M., Arruda-Carvalho M. Starting at the endophenotype: a role for alpha-CaMKII in schizophrenia?. Mol. Brain 2008, 1:5. 10.1186/1756-6606-1-5.
58. Fromer M., Pocklington A.J., Kavanagh D.H., Williams H.J., Dwyer S., Gormley P., Georgieva L., Rees E., Palta P., Ruderfer D.M., Carrera N., Humphreys I., Johnson J.S., Roussos P., Barker D.D., Banks E., Milanova V., Grant S.G., Hannon E., Rose S.A., Chambert K., Mahajan M., Scolnick E.M., Moran J.L., Kirov G., Palotie A., McCarroll S.A., Holmans P., Sklar P., Owen M.J., Purcell S.M., O'Donovan M.C. De novo mutations in schizophrenia implicate synaptic networks. Nature 2014, 506(7487):179-184. 10.1038/nature12929.
59. Garay P.A., McAllister A.K. Novel roles for immune molecules in neural development: implications for neurodevelopmental disorders. Front. Synaptic Neurosci. 2010, 2:136. 10.3389/fnsyn.2010.00136.
60. Girirajan S., Dennis M.Y., Baker C., Malig M., Coe B.P., Campbell C.D., Mark K., Vu T.H., Alkan C., Cheng Z., Biesecker L.G., Bernier R., Eichler E.E. Refinement and discovery of new hotspots of copy-number variation associated with autism spectrum disorder. Am. J. Hum. Genet. 2013, 92(2):221-237. 10.1016/j.ajhg.2012.12.016.
61. Grant S.G. Synaptopathies: diseases of the synaptome. Curr. Opin. Neurobiol. 2012, 22(3):522-529. 10.1016/j.conb.2012.02.002.
62. Guerini F.R., Bolognesi E., Chiappedi M., Manca S., Ghezzo A., Agliardi C., Sotgiu S., Usai S., Matteoli M., Clerici M. SNAP-25 single nucleotide polymorphisms are associated with hyperactivity in autism spectrum disorders. Pharmacol. Res. 2011, 64(3):283-288. 10.1016/j.phrs.2011.03.015.
63. Hahn C.G., Banerjee A., Macdonald M.L., Cho D.S., Kamins J., Nie Z., Borgmann-Winter K.E., Grosser T., Pizarro A., Ciccimaro E., Arnold S.E., Wang H.Y., Blair I.A. The post-synaptic density of human postmortem brain tissues: an experimental study paradigm for neuropsychiatric illnesses. PLoS ONE 2009, 4(4):e5251. 10.1371/journal.pone.0005251.
64. Hartinger J., Stenius K., Högemann D., Jahn R. 16-BAC/SDS-PAGE: a two-dimensional gel electrophoresis system suitable for the separation of integral membrane proteins. Anal. Biochem. 1996, 240(1):126-133. 10.1006/abio.1996.0339.
65. Hazlett E.A., Buchsbaum M.S., Hsieh P., Haznedar M.M., Platholi J., LiCalzi E.M., Cartwright C., Hollander E. Regional glucose metabolism within cortical Brodmann areas in healthy individuals and autistic patients. Neuropsychobiology 2004, 49(3):115-125. 10.1159/000076719.
66. Häfner H., Maurer K., Trendler G., an der Heiden W., Schmidt M., Könnecke R. Schizophrenia and depression: challenging the paradigm of two separate diseases-a controlled study of schizophrenia, depression and healthy controls. Schizophr. Res. 2005, 77(1):11-24.
67. Hell J.W. CaMKII: claiming center stage in postsynaptic function and organization. Neuron 2014, 81(2):249-265. 10.1016/j.neuron.2013.12.024.
68. Hjelm B.E., Rollins B., Mamdani F., Lauterborn J.C., Kirov G., Lynch G., Gall C.M., Sequeira A., Vawter M.P. Evidence of mitochondrial dysfunction within the complex genetic etiology of schizophrenia. Mol. Neuropsychiatry 2015, 1(4):201-219. 10.1159/000441252.
69. Hosack D.A., Dennis G., Sherman B.T., Lane H.C., Lempicki R.A. Identifying biological themes within lists of genes with EASE. Genome Biol. 2003, 4(10):R70. 10.1186/gb-2003-4-10-r70.
70. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4(1):44-57. 10.1038/nprot.2008.211.
71. Ikeda M., Hikita T., Taya S., Uraguchi-Asaki J., Toyo-oka K., Wynshaw-Boris A., Ujike H., Inada T., Takao K., Miyakawa T., Ozaki N., Kaibuchi K., Iwata N. Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia. Hum. Mol. Genet. 2008, 17(20):3212-3222. 10.1093/hmg/ddn217.
72. Ito M., Depaz I., Wilce P., Suzuki T., Niwa S., Matsumoto I. Expression of human neuronal protein 22, a novel cytoskeleton-associated protein, was decreased in the anterior cingulate cortex of schizophrenia. Neurosci. Lett. 2005, 378(3):125-130. 10.1016/j.neulet.2004.12.079.
73. Iwata K., Matsuzaki H., Tachibana T., Ohno K., Yoshimura S., Takamura H., Yamada K., Matsuzaki S., Nakamura K., Tsuchiya K.J., Matsumoto K., Tsujii M., Sugiyama T., Katayama T., Mori N. N-ethylmaleimide-sensitive factor interacts with the serotonin transporter and modulates its trafficking: implications for pathophysiology in autism. Mol. Autism. 2014, 5:33. 10.1186/2040-2392-5-33.
74. Jellinger K.A. Lewy body/alpha-synucleinopathy in schizophrenia and depression: a preliminary neuropathological study. Acta Neuropathol. 2009, 117(4):423-427. 10.1007/s00401-009-0492-5.
75. Kalkman H.O. Potential opposite roles of the extracellular signal-regulated kinase (ERK) pathway in autism spectrum and bipolar disorders. Neurosci. Biobehav. Rev. 2012, 36(10):2206-2213. 10.1016/j.neubiorev.2012.07.008.
76. Kerner J., Lee K., Tandler B., Hoppel C.L. VDAC proteomics: post-translation modifications. Biochim. Biophys. Acta 2012, 1818(6):1520-1525. 10.1016/j.bbamem.2011.11.013.
77. Kido M., Nakamura Y., Nemoto K., Takahashi T., Aleksic B., Furuichi A., Nakamura Y., Ikeda M., Noguchi K., Kaibuchi K., Iwata N., Ozaki N., Suzuki M. The polymorphism of YWHAE, a gene encoding 14-3-3 epsilon, and brain morphology in schizophrenia: a voxel-based morphometric study. PLoS ONE 2014, 9(8):e103571. 10.1371/journal.pone.0103571.
78. Kim S.W., Cho T., Lee S. Phospholipase C-β1 Hypofunction in the Pathogenesis of Schizophrenia. Front. Psychiatry 2015, 17(6):159. 10.3389/fpsyt.2015.00159.
79. Klemmer P., Meredith R.M., Holmgren C.D., Klychnikov O.I., Stahl-Zeng J., Loos M., van der Schors R.C., Wortel J., de Wit H., Spijker S., Rotaru D.C., Mansvelder H.D., Smit A.B., Li K.W. Proteomics, ultrastructure, and physiology of hippocampal synapses in a fragile X syndrome mouse model reveal presynaptic phenotype. J. Biol. Chem. 2011, 286(29):25495-25504. 10.1074/jbc.M110.210260.
80. Knuesel I., Chicha L., Britschgi M., Schobel S.A., Bodmer M., Hellings J.A., Toovey S., Prinssen E.P. Maternal immune activation and abnormal brain development across CNS disorders. Nat. Rev. Neurol. 2014, 10(11):643-660. 10.1038/nrneurol.2014.187.
81. Koenigs M., Grafman J. The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex. Behav. Brain Res. 2009, 201(2):239-243. 10.1016/j.bbr.2009.03.004.
82. Konopaske G.T., Lange N., Coyle J.T., Benes F.M. Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder. JAMA Psychiatry 2014, 71(12):1323-1331. 10.1001/jamapsychiatry.2014.1582.
83. Kovács Z., Kékesi K.A., Szilágyi N., Abrahám I., Székács D., Király N., Papp E., Császár I., Szego E., Barabás K., Péterfy H., Erdei A., Bártfai T., Juhász G. Facilitation of spike-wave discharge activity by lipopolysaccharides in Wistar Albino Glaxo/Rijswijk rats. Neuroscience 2006, 140(2):731-742. 10.1016/j.neuroscience.2006.02.023.
84. Labouesse M.A., Dong E., Grayson D.R., Guidotti A., Meyer U. Maternal immune activation induces GAD1 and GAD2 promoter remodeling in the offspring prefrontal cortex. Epigenetics 2015, 10(12):1143-1155. 10.1080/15592294.2015.1114202.
85. Lo Vasco V.R., Cardinale G., Polonia P. Deletion of PLCB1 gene in schizophrenia-affected patients. J. Cell Mol. Med. 2012, 16(4):844-851. 10.1111/j.1582-4934.2011.01363.x.
86. Macfarlane D.E. Two dimensional benzyldimethyl-n-hexadecylammonium chloride-sodium dodecyl sulfate preparative polyacrylamide gel electrophoresis: a high capacity high resolution technique for the purification of proteins from complex mixtures. Anal. Biochem. 1989, 176(2):457-463. 10.1016/0003-2697(89)90342-4.
87. Marco E.J., Khatibi K., Hill S.S., Siegel B., Arroyo M.S., Dowling A.F., Neuhaus J.M., Sherr E.H., Hinkley L.N., Nagarajan S.S. Children with autism show reduced somatosensory response: an MEG study. Autism Res. 2012, 5(5):340-351. 10.1002/aur.1247.
88. Martins-de-Souza D., Gattaz W.F., Schmitt A., Rewerts C., Marangoni S., Novello J.C., Maccarrone G., Turck C.W., Dias-Neto E. Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis. J. Neural Transm. (Vienna) 2009, 116(3):275-289. 10.1007/s00702-008-0156-y.
89. Matthews P.R., Eastwood S.L., Harrison P.J. Reduced myelin basic protein and actin-related gene expression in visual cortex in schizophrenia. PLoS ONE 2012, 7(6):e38211. 10.1371/journal.pone.0038211.
90. Mednick S.A., Machon R.A., Huttunen M.O., Bonett D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch. Gen. Psychiatry 1988, 45(2):189-192. 10.1001/archpsyc.1988.01800260109013.
91. Meyer U., Feldon J., Fatemi S.H. In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci. Biobehav. Rev. 2009, 33(7):1061-1079. 10.1016/j.neubiorev.2009.05.001.
92. Meyer U., Feldon J., Yee B.K. A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr. Bull. 2009, 35(5):959-972. 10.1093/schbul/sbn022.
93. Meyer U., Feldon J., Dammann O. Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?. Pediatr. Res. 2011, 69(5 Pt 2):26R-33R. 10.1203/PDR.0b013e318212c196.
94. Meyer U., Feldon J., Schedlowski M., Yee B.K. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci. Biobehav. Rev. 2005, 29(6):913-947.
95. Meyer U. Developmental neuroinflammation and schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 42:20-34. 10.1016/j.pnpbp.2011.11.003.
96. Middleton F.A., Mirnics K., Pierri J.N., Lewis D.A., Levitt P. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J. Neurosci. 2002, 22(7):2718-2729.
97. Miles J.H. Autism spectrum disorders-a genetics review. Genet. Med. 2011, 13(4):278-294. 10.1097/GIM.0b013e3181ff67ba.
98. Mirnics K., Middleton F.A., Marquez A., Lewis D.A., Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 2000, 28(1):53-67. 10.1016/S0896-6273(00)00085-4.
99. Munford R.S. Murine responses to endotoxin: another dirty little secret?. J. Infect. Dis. 2010, 201(2):175-177. 10.1086/649558.
100. Nicole L., Lesage A., Lalonde P. Lower incidence and increased male:female ratio in schizophrenia. Br. J. Psychiatry 1992, 161:556-557. 10.1192/bjp.161.4.556.
101. Ohnuma T., Kato H., Arai H., Faull R.L., McKenna P.J., Emson P.C. Gene expression of PSD95 in prefrontal cortex and hippocampus in schizophrenia. NeuroReport 2000, 11(14):3133-3137. 10.1097/00001756-200009280-00019.
102. Oskvig D.B., Elkahloun A.G., Johnson K.R., Phillips T.M., Herkenham M. Maternal immune activation by LPS selectively alters specific gene expression profiles of interneuron migration and oxidative stress in the fetus without triggering a fetal immune response. Brain Behav. Immun. 2012, 26(4):623-634. 10.1016/j.bbi.2012.01.015.
103. Ozaki T., Yamashita T., Ishiguro S. Mitochondrial m-calpain plays a role in the release of truncated apoptosis-inducing factor from the mitochondria. Biochim. Biophys. Acta 2009, 1793(12):1848-1859. 10.1016/j.bbamcr.2009.10.002.
104. Parlapani E., Schmitt A., Erdmann A., Bernstein H.G., Breunig B., Gruber O., Petroianu G., von Wilmsdorff M., Schneider-Axmann T., Honer W., Falkai P. Association between myelin basic protein expression and left entorhinal cortex pre-alpha cell layer disorganization in schizophrenia. Brain Res. 2009, 1301:126-134. 10.1016/j.brainres.2009.09.007.
105. Patterson P.H. Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav. Brain Res. 2009, 204(2):313-321. 10.1016/j.bbr.2008.12.016.
106. Pennington K., Beasley C.L., Dicker P., Fagan A., English J., Pariante C.M., Wait R., Dunn M.J., Cotter D.R. Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder. Mol. Psychiatry 2008, 13(12):1102-1117. 10.1038/sj.mp.4002098.
107. Penzes P., Cahill M.E., Jones K.A., VanLeeuwen J.E., Woolfrey K.M. Dendritic spine pathology in neuropsychiatric disorders. Nat. Neurosci. 2011, 14(3):285-293. 10.1038/nn.2741.
108. Phillips G.R., Huang J.K., Wang Y., Tanaka H., Shapiro L., Zhang W., Shan W.S., Arndt K., Frank M., Gordon R.E., Gawinowicz M.A., Zhao Y., Colman D.R. The presynaptic particle web: ultrastructure, composition, dissolution, and reconstitution. Neuron 2001, 32(1):63-77. 10.1016/S0896-6273(01)00450-0.
109. Phillips G.R., Florens L., Tanaka H., Khaing Z.Z., Fidler L., Yates J.R., Colman D.R. Proteomic comparison of two fractions derived from the transsynaptic scaffold. J. Neurosci. Res. 2005, 81(6):762-775. 10.1002/jnr.20614.
110. Pickett J., London E. The neuropathology of autism: a review. J. Neuropathol. Exp. Neurol. 2005, 64(11):925-935.
111. Poling J.S., Frye R.E., Shoffner J., Zimmerman A.W. Developmental regression and mitochondrial dysfunction in a child with autism. J. Child Neurol. 2006, 21(2):170-172. 10.2310/7010.2006.00032.
112. Priller C., Bauer T., Mitteregger G., Krebs B., Kretzschmar H.A., Herms J. Synapse formation and function is modulated by the amyloid precursor protein. J. Neurosci. 2006, 26(27):7212-7221. 10.1523/JNEUROSCI.1450-06.2006.
113. Ratnayake U., Quinn T., Walker D.W., Dickinson H. Cytokines and the neurodevelopmental basis of mental illness. Front. Neurosci. 2013, 7:180. 10.3389/fnins.2013.00180.
114. Reisinger S., Khan D., Kong E., Berger A., Pollak A., Pollak D.D. The poly(I:C)-induced maternal immune activation model in preclinical neuropsychiatric drug discovery. Pharmacol. Ther. 2015, 149:213-226. 10.1016/j.pharmthera.2015.01.001.
115. Reisinger S.N., Kong E., Khan D., Schulz S., Ronovsky M., Berger S., Horvath O., Cabatic M., Berger A., Pollak D.D. Maternal immune activation epigenetically regulates hippocampal serotonin transporter levels. Neurobiol. Stress 2016, 10.1016/j.ynstr.2016.02.007.
116. Roth T.L., Lubin F.D., Sodhi M., Kleinman J.E. Epigenetic mechanisms in schizophrenia. Biochim. Biophys. Acta 2009, 1790(9):869-877. 10.1016/j.bbagen.2009.06.009.
117. Sasson N.J., Pinkham A.E., Carpenter K.L., Belger A. The benefit of directly comparing autism and schizophrenia for revealing mechanisms of social cognitive impairment. J. Neurodev Disord. 2011, 3(2):87-100. 10.1007/s11689-010-9068-x.
118. Schanen N.C. Epigenetics of autism spectrum disorders. Hum. Mol. Genet. 2006, 15(20):R138-R150. 10.1093/hmg/ddl213.
119. Schubert K.O., Föcking M., Prehn J.H., Cotter D.R. Hypothesis review: are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder?. Mol. Psychiatry 2012, 17(7):669-681. 10.1038/mp.2011.123.
120. Selemon L.D. A role for synaptic plasticity in the adolescent development of executive function. Transl. Psychiatry 2013, 3:e238. 10.1038/tp.2013.7.
121. Seshadri S., Zeledon M., Sawa A. Synapse-specific contributions in the cortical pathology of schizophrenia. Neurobiol. Dis. 2013, 53:26-35. 10.1016/j.nbd.2013.01.009.
122. Singh V.K., Warren R.P., Odell J.D., Warren W.L., Cole P. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav. Immun. 1993, 7(1):97-103. 10.1006/brbi.1993.1010.
123. Skafidas E., Testa R., Zantomio D., Chana G., Everall I.P., Pantelis C. Predicting the diagnosis of autism spectrum disorder using gene pathway analysis. Mol. Psychiatry 2014, 19(4):504-510. 10.1038/mp.2012.126.
124. Smalla K.H., Mikhaylova M., Sahin J., Bernstein H.G., Bogerts B., Schmitt A., van der Schors R., Smit A.B., Li K.W., Gundelfinger E.D., Kreutz M.R. A comparison of the synaptic proteome in human chronic schizophrenia and rat ketamine psychosis suggest that prohibitin is involved in the synaptic pathology of schizophrenia. Mol. Psychiatry 2008, 13(9):878-896. 10.1038/mp.2008.60.
125. Smith S.E., Li J., Garbett K., Mirnics K., Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci. 2007, 27(40):10695-10702. 10.1523/JNEUROSCI.2178-07.2007.
126. Smith S.E., Elliott R.M., Anderson M.P. Maternal immune activation increases neonatal mouse cortex thickness and cell density. J. Neuroimmune Pharmacol. 2012, 7(3):529-532. 10.1007/s11481-012-9372-1.
127. Sørensen H.J., Mortensen E.L., Reinisch J.M., Mednick S.A. Association between prenatal exposure to bacterial infection and risk of schizophrenia. Schizophr. Bull. 2009, 35(3):631-637. 10.1093/schbul/sbn121.
128. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci. Biobehav. Rev. 2000, 24(4):417-463. 10.1016/S0149-7634(00)00014-2.
129. Stasyk T., Huber L.A. Zooming in: fractionation strategies in proteomics. Proteomics 2004, 4(12):3704-3716. 10.1002/pmic.200401048.
130. Steffek A.E., McCullumsmith R.E., Haroutunian V., Meador-Woodruff J.H. Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia. Schizophr. Res. 2008, 103(1-3):71-82. 10.1016/j.schres.2008.04.032.
131. Sun J., Wan C., Jia P., Fanous A.H., Kendler K.S., Riley B.P., Zhao Z. Application of systems biology approach identifies and validates GRB2 as a risk gene for schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample. Schizophr. Res. 2011, 125(2-3):201-208. 10.1016/j.schres.2010.12.002.
132. Szego E.M., Janáky T., Szabó Z., Csorba A., Kompagne H., Müller G., Lévay G., Simor A., Juhász G., Kékesi K.A. A mouse model of anxiety molecularly characterized by altered protein networks in the brain proteome. Eur. Neuropsychopharmacol. 2010, 20(2):96-111. 10.1016/j.euroneuro.2009.11.003.
133. Tabarés-Seisdedos R., Rubenstein J.L. Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer. Mol. Psychiatry 2009, 14(6):563-589. 10.1038/mp.2009.2.
134. Tan M.L., Dyck B.A., Gabriele J., Daya R.P., Thomas N., Sookram C., Basu D., Ferro M.A., Chong V.Z., Mishra R.K. Synapsin II gene expression in the dorsolateral prefrontal cortex of brain specimens from patients with schizophrenia and bipolar disorder: effect of lifetime intake of antipsychotic drugs. Pharmacogenomics J. 2014, 14(1):63-69. 10.1038/tpj.2013.6.
135. Tang B., Jia H., Kast R.J., Thomas E.A. Epigenetic changes at gene promoters in response to immune activation in utero. Brain Behav. Immun. 2013, 30:168-175. 10.1016/j.bbi.2013.01.086.
136. Tang G., Gutierrez Rios P., Kuo S.H., Akman H.O., Rosoklija G., Tanji K., Dwork A., Schon E.A., Dimauro S., Goldman J., Sulzer D. Mitochondrial abnormalities in temporal lobe of autistic brain. Neurobiol. Dis. 2013, 54:349-361. 10.1016/j.nbd.2013.01.006.
137. Tcherepanov A.A., Sokolov B.P. Age-related abnormalities in expression of mRNAs encoding synapsin 1A, synapsin 1B, and synaptophysin in the temporal cortex of schizophrenics. J. Neurosci. Res. 1997, 49(5):639-644. 10.1002/(SICI)1097-4547(19970901)49:53.0.CO;2-Q.
138. Thoma R.J., Hanlon F.M., Huang M., Miller G.A., Moses S.N., Weisend M.P., Jones A., Paulson K.M., Irwin J., Cañive J.M. Impaired secondary somatosensory gating in patients with schizophrenia. Psychiatry Res. 2007, 151(3):189-199.
139. Toma C., Hervás A., Balmaña N., Vilella E., Aguilera F., Cuscó I., del Campo M., Caballero R., De Diego-Otero Y., Ribasés M., Cormand B., Bayés M. Association study of six candidate genes asymmetrically expressed in the two cerebral hemispheres suggests the involvement of BAIAP2 in autism. J. Psychiatr. Res. 2011, 45(2):280-282. 10.1016/j.jpsychires.2010.09.001.
140. Tuchman R., Rapin I. Epilepsy in autism. Lancet Neurol. 2002, 1(6):352-358.
141. Urakubo A., Jarskog L.F., Lieberman J.A., Gilmore J.H. Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain. Schizophr. Res. 2001, 47(1):27-36. 10.1016/S0920-9964(00)00032-3.
142. Völgyi K., Gulyássy P., Háden K., Kis V., Badics K., Kékesi K.A., Simor A., Györffy B., Tóth E.A., Lubec G., Juhász G., Dobolyi A. Synaptic mitochondria: a brain mitochondria cluster with a specific proteome. J. Proteomics 2015, 120:142-157. 10.1016/j.jprot.2015.03.005.
143. Wang X.J. Neurophysiological and computational principles of cortical rhythms in cognition. Physiol. Rev. 2010, 90(3):1195-1268. 10.1152/physrev.00035.2008.
144. Wang Y., Fang Y., Zhang F., Xu M., Zhang J., Yan J., Ju W., Brown W.T., Zhong N. Hypermethylation of the enolase gene (ENO2) in autism. Eur. J. Pediatr. 2014, 173(9):1233-1244. 10.1007/s00431-014-2311-9.
145. Washizuka S., Kametani M., Sasaki T., Tochigi M., Umekage T., Kohda K., Kato T. Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with schizophrenia in the Japanese population. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2006, 141B(3):301-304. 10.1002/ajmg.b.30285.
146. Weir R.K., Forghany R., Smith S.E., Patterson P.H., McAllister A.K., Schumann C.M., Bauman M.D. Preliminary evidence of neuropathology in nonhuman primates prenatally exposed to maternal immune activation. Brain Behav. Immun. 2015, 48:139-146. 10.1016/j.bbi.2015.03.009.
147. Whittaker V.P. Thirty years of synaptosome research. J. Neurocytol. 1993, 22(9):735-742. 10.1007/BF01181319.
148. Wiedenmann B., Franke W.W. Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell 1985, 41(3):1017-1028. 10.1016/S0092-8674(85)80082-9.
149. Wilhelm B.G., Mandad S., Truckenbrodt S., Kröhnert K., Schäfer C., Rammner B., Koo S.J., Claßen G.A., Krauss M., Haucke V., Urlaub H., Rizzoli S.O. Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins. Science 2014, 344(6187):1023-1028. 10.1126/science.1252884.
150. Xuan I.C., Hampson D.R. Gender-dependent effects of maternal immune activation on the behavior of mouse offspring. PLoS ONE 2014, 9(8):e104433. 10.1371/journal.pone.0104433.
151. Yamasaki N., Maekawa M., Kobayashi K., Kajii Y., Maeda J., Soma M., Takao K., Tanda K., Ohira K., Toyama K., Kanzaki K., Fukunaga K., Sudo Y., Ichinose H., Ikeda M., Iwata N., Ozaki N., Suzuki H., Higuchi M., Suhara T., Yuasa S., Miyakawa T. Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders. Mol Brain. 2008, 1:6. 10.1186/1756-6606-1-6.
152. Yao J.K., Keshavan M.S. Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view. Antioxid. Redox Signal. 2011, 15(7):2011-2035. 10.1089/ars.2010.3603.
153. Yoshimura Y., Yamauchi Y., Shinkawa T., Taoka M., Donai H., Takahashi N., Isobe T., Yamauchi T. Molecular constituents of the postsynaptic density fraction revealed by proteomic analysis using multidimensional liquid chromatography-tandem mass spectrometry. J. Neurochem. 2004, 88(3):759-768. 10.1046/j.1471-4159.2003.02136.x.
154. Zerbo O., Iosif A.M., Walker C., Ozonoff S., Hansen R.L., Hertz-Picciotto I. Is maternal influenza or fever during pregnancy associated with autism or developmental delays? Results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) study. J. Autism Dev. Disord. 2013, 43(1):25-33. 10.1007/s10803-012-1540-x.
155. Zuckerman L., Rehavi M., Nachman R., Weiner I. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 2003, 28(10):1778-1789. 10.1038/sj.npp.1300248.
156. Zuko A., Kleijer K.T., Oguro-Ando A., Kas M.J., van Daalen E., van der Zwaag B., Burbach J.P. Contactins in the neurobiology of autism. Eur. J. Pharmacol. 2013, 719(1-3):63-74. 10.1016/j.ejphar.2013.07.016.